Hong Yuan

Dr. Hong Yuan

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2018 in JCI Insight
Verified
Journal Article
Open access
PDF file
NCNing Cheng
Ning Cheng
RWRebekah Watkins-Schulz
Rebekah Watkins-Schulz
RJRobert D. Junkins
Robert D. Junkins
CDClément N. David
Clément N. David
BJBrandon M. Johnson
Brandon M. Johnson
JTJenny P-Y Ting
Jenny P-Y Ting
Triple-negative breast cancer (TNBC) has few therapeutic options, and alternative approaches are urgently needed. Stimulator of IFN genes (STING) is becoming an exciting target for therapeutic adjuvants. However, STING resides inside the cell, and the intracellular delivery of CDNs, such as cGAMP, is required for the optimal activation of STING. We show that liposomal nanoparticle-delivered cGAMP (cGAMP-NP) activates STING more effectively than soluble cGAMP. These particles induce innate and adaptive host immune responses to preexisting tumors in both orthotopic and genetically engineered models of basal-like TNBC. cGAMP-NPs also reduce melanoma tumor load, with limited responsivity to anti–PD-L1. Within the tumor microenvironment, cGAMP-NPs direct both mouse and human macrophages (M), reprograming from protumorigenic M2-like phenotype toward M1-like phenotype; enhance MHC and costimulatory molecule expression; reduce M2 biomarkers; increase IFN-γ–producing T cells; augment tumor apoptosis; and increase CD4 + and CD8 + T cell infiltration. Activated T cells are required for tumor suppression, as their depletion reduces antitumor activity. Importantly, cGAMP-NPs prevent the formation of secondary tumors, and a single dose is sufficient to inhibit TNBC. These data suggest that a minimal system comprised of cGAMP-NP alone is sufficient to modulate the tumor microenvironment to effectively control PD-L1–insensitive TNBC.

1 November 2006 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
HYHong Yuan
Hong Yuan
MGM. Waleed Gaber
M. Waleed Gaber
KBKelli Boyd
Kelli Boyd
CWChristy M. Wilson
Christy M. Wilson
MKMohammad F. Kiani
Mohammad F. Kiani
TMThomas E. Merchant
Thomas E. Merchant

29 April 2022 in Science Advances
Verified
Journal Article
Open access
EOEsteban A. Oyarzabal
Esteban A. Oyarzabal
LHLi-Ming Hsu
Li-Ming Hsu
MDManasmita Das
Manasmita Das
TCTzu-Hao Harry Chao
Tzu-Hao Harry Chao
JZJingheng Zhou
Jingheng Zhou
YSYen-Yu Ian Shih
Yen-Yu Ian Shih
The default mode network (DMN) of the brain is functionally associated with a wide range of behaviors. In this study, we used functional magnetic resonance imaging (fMRI), positron emission tomography (PET), and spectral fiber photometry to investigate the selective neuromodulatory effect of norepinephrine (NE)–releasing noradrenergic neurons in the locus coeruleus (LC) on the mouse DMN. Chemogenetic-induced tonic LC activity decreased cerebral blood volume (CBV) and glucose uptake and increased synchronous low-frequency fMRI activity within the frontal cortices of the DMN. Fiber photometry results corroborated these findings, showing that LC-NE activation induced NE release, enhanced calcium-weighted neuronal spiking, and reduced CBV in the anterior cingulate cortex. These data suggest that LC-NE alters conventional coupling between neuronal activity and CBV in the frontal DMN. We also demonstrated that chemogenetic activation of LC-NE neurons strengthened functional connectivity within the frontal DMN, and this effect was causally mediated by reduced modulatory inputs from retrosplenial and hippocampal regions to the association cortices of the DMN.

1 April 2004 in Brain Research Protocols
Verified
Journal Article
Closed access
MGM.WAleed Gaber
M.WAleed Gaber
HYHong Yuan
Hong Yuan
JKJohn T Killmar
John T Killmar
MNMichael D Naimark
Michael D Naimark
MKMohammad F Kiani
Mohammad F Kiani
TMThomas E Merchant
Thomas E Merchant

12 August 2020 in Molecules
Verified
Journal Article
Open access
PDF file
DPDarpan N. Pandya
Darpan N. Pandya
ASAkesh Sinha
Akesh Sinha
HYHong Yuan
Hong Yuan
LMLysette Mutkus
Lysette Mutkus
KSKristina Stumpf
Kristina Stumpf
Thaddeus WadasThaddeus Wadas
Thaddeus Wadas
Glioblastoma multiforme (GBM) is the most aggressive glioma of the primary central nervous system. Due to the lack of effective treatment options, the prognosis for patients remains bleak. Fibroblast activation protein alpha (FAP), a 170 kDa type II transmembrane serine protease was observed to be expressed on glioma cells and within the glioma tumor microenvironment. To understand the utility of targeting FAP in this tumor type, the immuno-PET radiopharmaceutical [89Zr]Zr-Df-Bz-F19 mAb was prepared and Lindmo analysis was used for its in vitro evaluation using the U87MG cell line, which expresses FAP endogenously. Lindmo analysis revealed an association constant (Ka) of 10−8 M−1 and an immunoreactivity of 52%. Biodistribution studies in U87MG tumor-bearing mice revealed increasing radiotracer retention in tumors over time, leading to average tumor-to-muscle ratios of 3.1, 7.3, 7.2, and 8.3 at 2, 24, 48 and 72 h, respectively. Small animal PET corroborated the biodistribution studies; tumor-to-muscle ratios at 2, 24, 48, and 72 h were 2.0, 5.0, 6.1 and 7.8, respectively. Autoradiography demonstrated accumulated activity throughout the interior of FAP+ tumors, while sequential tumor sections stained positively for FAP expression. Conversely, FAP− tissues retained minimal radioactivity and were negative for FAP expression by immunohistochemistry. These results demonstrate FAP as a promising biomarker that may be exploited to diagnose and potentially treat GBM and other neuroepithelial cancers.

21 January 2022 in Journal of Controlled Release
Verified
Journal Article
Closed access
ATAnne M. Talkington
Anne M. Talkington
MMMorgan D. McSweeney
Morgan D. McSweeney
TWTimothy Wessler
Timothy Wessler
MRMarielle Rath
Marielle Rath
ZLZibo Li
Zibo Li
SLSamuel K. Lai
Samuel K. Lai